LAXMIDENTL203.30

Laxmi Dental Limited

· Pharma & Health
AnnualQuarterly₹ CrorePeersFABTECHTARSONSFISCHERGKBMcap ₹1,117 Cr
View
In ₹ Crore except Per Share
12 Months Ending
Q3 FY25
31/12/2024
Q4 FY25
31/03/2025
Q1 FY26
30/06/2025
Q2 FY26
30/09/2025
Q3 FY26
31/12/2025
Q4 FY26
31/03/2026
Q1 FY27
30/06/2026
Revenue from Operations61.760.765.672.366.074.074.7
Other Income0.61.61.72.42.12.42.3
Total Income62.262.367.374.768.176.377.0
Expenses
+ Cost of Materials Consumed6.94.12.46.94.011.89.1
+ Purchases of Stock-in-Trade7.79.313.615.615.412.99.6
+ Changes in Inventories1.5-0.51.60.20.7-2.9-2.7
+ Employee Benefit Expense21.824.423.625.825.926.828.4
+ Finance Costs1.51.30.50.20.30.30.3
+ Depreciation & Amortisation4.04.33.63.74.24.44.3
+ Other Expenses14.213.812.512.713.011.915.9
Total Expenses57.556.757.765.263.665.265.0
EBITDA9.69.511.911.07.013.514.4
EBIT5.75.28.37.32.89.110.0
Profit
PBT before Exceptional Items4.75.69.69.44.611.112.0
+ Exceptional Items0.00.40.00.0-5.80.00.0
Pretax Income4.76.09.69.4-1.211.112.0
+ Current Tax0.30.92.02.31.90.42.8
+ Deferred Tax0.71.60.3-0.4-4.00.1-0.4
Tax Expense1.12.52.31.9-2.20.52.5
+ Share of Associates & JVs1.20.71.01.01.0-0.50.8
Net Income4.84.38.38.52.010.110.3
+ Net Income — Continuing Ops3.63.57.37.60.910.69.5
+ Other Comprehensive Income0.0-0.6-0.10.20.01.3-0.0
Total Comprehensive Income4.93.78.28.72.011.410.3
Net Income to Common4.84.38.48.52.010.110.3
Minority Interest0.0-0.0-0.1-0.0-0.00.00.0
Per Share
Basic EPS0.880.791.531.590.371.831.87
Diluted EPS0.880.781.521.580.361.831.87
Other Comprehensive Income — detail
+ Other Comprehensive Income-0.6-0.10.20.01.3-0.0
+ Items NOT to be Reclassified to P&L0.1-0.6-0.2-0.2-0.20.70.0
+ Tax on Items NOT to be Reclassified0.0-0.0-0.0-0.10.20.0
+ Items to be Reclassified to P&L0.10.30.2-0.0
+ Tax on Items to be Reclassified-0.00.00.00.0-0.70.0
+ Tax on Items to be Reclassified — alt tag0.0
Comprehensive Income — Owners of Parent0.03.7-0.10.20.01.3-0.0
Comprehensive Income — Non-controlling Interests0.0-0.00.00.00.00.00.0
Per Share — as-filed variants
Basic EPS — Continuing Operations0.880.791.531.590.371.831.87
Diluted EPS — Continuing Operations0.880.781.521.580.361.831.87
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit45.647.848.149.545.952.158.7
Gross Margin %73.9078.7573.3168.5469.5470.4978.59
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)4.75.69.69.44.611.112.0
− Exceptional Items (reconciliation)0.00.40.00.0-5.80.00.0
Net Income Adj (tax-effected)4.84.08.38.54.310.110.3
EPS Adj0.880.751.531.590.811.831.87
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value2.002.002.002.002.002.002.00
Filed Debt Equity0.000.000.000.000.00
Filed Dscr0.000.010.000.000.000.09
Filed Iscr0.000.080.000.000.000.47
Paid Up Equity Capital10.311.011.011.011.011.011.0
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: Q1 FY27 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.